DR TB

DR TB

Interactive Data Dashboards

Track the HIV & TB response

Key indicators, province breakdowns and downloadable graphs.

  • 400 people in SA with highly drug-resistant TB to get new three-drug regimen

    Treating highly drug-resistant forms of tuberculosis can take anything from nine to 24 months and patients have to contend with various unpleasant, and sometimes dangerous, side effects. A new six-month regimen made up of just three drugs that will be offered to 400 patients in South Africa might offer a better solution for some. Tiyese…

    ·

  • TB in children: Exciting treatment advances, but better tests badly needed

    Children shoulder approximately 12% of the global TB burden, and this proportion is likely higher in high TB burden countries. In South Africa, up to 30 000 children develop TB each year. Tiyese Jeranji spoke to TB expert, Dr Megan Palmer from Brooklyn Chest Hospital about treatment challenges and how to improve TB detection and treatment…

    ·

  • Drop in DR-TB detection points to “crisis” in SA’s TB response

    A leading TB doctor says that “it is no exaggeration to say there is a TB crisis in the country”, and that “the impact of this crisis could be even more devastating than COVID-19”. Kathryn Cleary explores the COVID-19 pandemic’s impact on South Africa’s TB response and the way forward.

    ·

  • Disability grant delays take heavy toll

    During the strictest phases of South Africa’s COVID-19 lockdown, the South African Social Security Agency effectively stopped accepting new disability grant applications. Elri Voigt explores what happened and speaks to two applicants on the impact the disruptions have had on their lives.

    ·

  • A convenient untruth: The TB Proof healthcare worker

    We were told the planned release date for an occupational health policy to protect healthcare workers was World tuberculosis Day, 24 March 2017. Three World TB Days later and with a new epidemic claiming the lives of healthcare workers we are still waiting for the policy, writes Dr Arne von Delft.

    ·